Our global presence
Beyond our core of permanent staff, we have a well-developed international network of experts and investigators who we engage as part of a broader Oxford Outcomes community. Key and established pillars of this network include our permanent Oxford Outcomes investigators group.
As a part of ICON plc we have a significant network built around our strong academic, regulatory and commercial links, giving us capability to undertake projects across Europe, North America, South America, Asia, Australasia and parts of Africa. Our recent acquisition increases global reach significantly and allows us to make use of a staff of 7,800 across 71 offices in 38 countries providing services that assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market.